enGene Therapeutics (ENGN) Current Assets (2022 - 2026)
enGene Therapeutics' Current Assets came in at $277.9 million for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 31.5% from $211.31 million a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics' Current Assets was $201.39 million, down 18.6% from FY2024.
- Current Assets carries a three-year compound annual growth rate of 107.4% (FY2022 to FY2025).
- Going back by fiscal year, Current Assets was $247.36 million in FY2024 (+189.5%), $85.44 million in FY2023 (+278.3%) and $22.58 million in FY2022.
- The five-year range for quarterly Current Assets is $22.58 million (fiscal Q4 2022) to $289.22 million (fiscal Q1 2026).
- Year-over-year, Current Assets has increased for three consecutive quarters, with growth averaging 45.5% over the last eight quarters.
- The fastest year-over-year change in Current Assets over five years came in fiscal Q4 2023 (growth of 278.3%), and the weakest in fiscal Q3 2025 (a decline of 19.6%).
- Business Quant data shows ENGN's Current Assets at $270 million (Q2 2026), $289.22 million (Q1 2026) and $201.39 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 277.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 277.90 Mn |
| Apr 30, 2026 | 270.00 Mn |
| Jan 31, 2026 | 289.22 Mn |
| Oct 31, 2025 | 201.39 Mn |
| Jul 31, 2025 | 211.31 Mn |
| Apr 30, 2025 | 227.97 Mn |
| Jan 31, 2025 | 222.32 Mn |
| Oct 31, 2024 | 247.36 Mn |
| Jul 31, 2024 | 262.69 Mn |
| Apr 30, 2024 | 269.61 Mn |
| Jan 31, 2024 | 89.58 Mn |
| Oct 31, 2023 | 85.44 Mn |
| Oct 31, 2022 | 22.58 Mn |
API Access
enGene Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();